PTX 4.65% 4.1¢ prescient therapeutics limited

CellPryme-M question, page-9

  1. 7,990 Posts.
    lightbulb Created with Sketch. 3424
    So, if I'm to interpret your take on it correctly, Peter Mac will pay PTX a licensing fee to incorporate Cell Pryme into their manufacturing? If so, a huge win-win for both parties and cancer patients, I'd think, esp given Peter Mac is globally renowned.

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $7.846K 186.5K

Buyers (Bids)

No. Vol. Price($)
5 290288 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 3226 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.